Guangdong VTR Bio-Tech Co (SZSE:300381) EV-to-EBIT : 79.15 (As of May. 20, 2024)

Guangdong VTR Bio-Tech Co EV-to-EBIT Chart

Guangdong VTR Bio-Tech Co Annual Data
	Trend	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
EV-to-EBIT		Get a 7-Day Free Trial					21.02	21.78	-122.31	19.50	639.86

Guangdong VTR Bio-Tech Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-EBIT	Get a 7-Day Free Trial															23.47	88.04	176.67	639.86	48.42

Competitive Comparison of Guangdong VTR Bio-Tech Co's EV-to-EBIT

For the Biotechnology subindustry, Guangdong VTR Bio-Tech Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Guangdong VTR Bio-Tech Co's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Guangdong VTR Bio-Tech Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Guangdong VTR Bio-Tech Co's EV-to-EBIT falls into.

Guangdong VTR Bio-Tech Co EV-to-EBIT Calculation

Guangdong VTR Bio-Tech Co's EV-to-EBIT for today is calculated as:

Guangdong VTR Bio-Tech Co's current Enterprise Value is ¥2,897.2 Mil.
Guangdong VTR Bio-Tech Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥36.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Guangdong VTR Bio-Tech Co  (SZSE:300381) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Guangdong VTR Bio-Tech Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Guangdong VTR Bio-Tech Co's Enterprise Value for the quarter that ended in Mar. 2024 was ¥1,772.4 Mil.
Guangdong VTR Bio-Tech Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥36.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Guangdong VTR Bio-Tech Co EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Guangdong VTR Bio-Tech Co's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Guangdong VTR Bio-Tech Co (SZSE:300381) Business Description